PCI, RXi extend preclinical collaboration

PCI Biotech Holding ASA (OSE:PCIB) and RXi Pharmaceuticals Corp. (NASDAQ:RXII) extended a 2015 preclinical research collaboration and will conduct new studies to assess the compatibility of the companies’ immuno-oncology technologies...